Upgrade to SI Premium - Free Trial

EU panel recommends Ionis olezarsen for severe hypertriglyceridemia

October 16, 2026 6:45 AM
Ionis Pharmaceuticals (Nasdaq: IONS) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA